These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24577883)

  • 21. Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.
    Bland KA; Harrison M; Zopf EM; Sousa MS; Currow DC; Ely M; Agar M; Butcher BE; Vaughan V; Dowd A; Martin P
    J Pain Symptom Manage; 2021 Sep; 62(3):e164-e176. PubMed ID: 33652095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care.
    Shin DW; Choi JE; Miyashita M; Choi JY; Kang J; Baik YJ; Mo HN; Park J; Kim HJ; Park EC
    J Pain Symptom Manage; 2011 Feb; 41(2):478-84. PubMed ID: 21145697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer.
    Koyama N; Matsumura C; Shitashimizu Y; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    BMC Cancer; 2021 Mar; 21(1):304. PubMed ID: 33757453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients.
    Arraras JI; de la Vega FA; Asin G; Rico M; Zarandona U; Eito C; Cambra K; Barrondo M; Errasti M; Verdún J; Rivadeneira J; Dominguez MA
    Qual Life Res; 2014 Apr; 23(3):849-55. PubMed ID: 24002479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
    Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
    Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
    Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
    Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life in Patients Treated with Palliative Radiotherapy for Advanced Lung Cancer and Lung Metastases.
    Koo K; Zeng L; Jon F; Chen E; Dennis K; Holden L; Zhang L; Caissie A; Nguyen J; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
    World J Oncol; 2011 Apr; 2(2):70-75. PubMed ID: 29147227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of three shortened questionnaires for assessment of quality of life in advanced cancer.
    Chiu L; Chiu N; Chow E; Cella D; Beaumont JL; Lam H; Popovic M; Bedard G; Poon M; Wong E; Zeng L; Bottomley A
    J Palliat Med; 2014 Aug; 17(8):918-23. PubMed ID: 24922521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A; Zeng L; Nguyen J; Zhang L; Jon F; Dennis K; Holden L; Culleton S; Koo K; Tsao M; Barnes E; Danjoux C; Sahgal A; Simmons C; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):125-33. PubMed ID: 21917431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do elderly patients with metastatic cancer have worse quality of life scores?
    Koo K; Zeng L; Chen E; Zhang L; Culleton S; Dennis K; Caissie A; Nguyen J; Holden L; Jon F; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
    Support Care Cancer; 2012 Sep; 20(9):2121-7. PubMed ID: 22081058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms and problems reported by patients with non-cancer diseases through open-ended questions in specialist palliative care: a national register-based study.
    Rojas-Concha L; Hansen MB; Groenvold M
    Support Care Cancer; 2024 Feb; 32(2):141. PubMed ID: 38305835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Controlled Trial of Betamethasone on Fatigue in Patients With Advanced Cancer.
    Miyazaki K; Ikenaga M; Sato T; Ueshima K; Nawata S; Horimatsu T; Komori E; Kirishima T; Kawabata K; Kawamura T; Kasai H; Suzukamo Y; Matsuzaki K; Kuwabara Y; Nakayama T;
    J Pain Symptom Manage; 2024 May; 67(5):393-401.e1. PubMed ID: 38331232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar R; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Support Care Cancer; 2016 Dec; 24(12):4871-4878. PubMed ID: 27465049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy.
    Pulenzas N; Khan L; Tsao M; Zhang L; Lechner B; Thavarajah N; Barnes E; Danjoux C; Holden L; Lauzon N; Sheehan P; Bedard G; Chow E
    Support Care Cancer; 2014 Jul; 22(7):1757-63. PubMed ID: 24510194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study.
    Rohde GE; Young T; Winstanley J; Arraras JI; Black K; Boyle F; Bredart A; Costantini A; Guo J; Irarrazaval ME; Kobayashi K; Kruizinga R; Navarro M; Omidvari S; Serpentini S; Spry N; van Laarhoven H; Yang G; Vivat B
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13145. PubMed ID: 31433533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.